Nkarta, Inc. financial data

Symbol
NKTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1150 Veterans Boulevard, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.48K % +18%
Debt-to-equity 25.2 % -22.3%
Return On Equity -27.1 % +26.1%
Return On Assets -21.7 % +21.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.6M shares +43.8%
Common Stock, Shares, Outstanding 49.2M shares +0.62%
Entity Public Float 38.4M USD -88.9%
Common Stock, Value, Issued 7K USD +40%
Weighted Average Number of Shares Outstanding, Basic 73.6M shares +49.9%
Weighted Average Number of Shares Outstanding, Diluted 73.6M shares +49.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 96.9M USD -3.35%
General and Administrative Expense 31.5M USD -10.3%
Operating Income (Loss) -128M USD +5.16%
Nonoperating Income (Expense) 17.8M USD +36%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -111M USD +9.58%
Earnings Per Share, Basic -1.88 USD/shares +23.6%
Earnings Per Share, Diluted -1.88 USD/shares +23.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57M USD +48.9%
Other Assets, Current 1.62M USD -44.7%
Assets, Current 290M USD +3.19%
Property, Plant and Equipment, Net 76.2M USD -1.87%
Operating Lease, Right-of-Use Asset 38.8M USD -4.23%
Other Assets, Noncurrent 4.64M USD +24.5%
Assets 532M USD +31.1%
Accounts Payable, Current 1.94M USD -54.8%
Employee-related Liabilities, Current 7.01M USD +16.4%
Accrued Liabilities, Current 13.8M USD -9.96%
Liabilities, Current 22.5M USD -12.4%
Operating Lease, Liability, Noncurrent 78.7M USD -5.65%
Other Liabilities, Noncurrent 5K USD -91.1%
Liabilities 101M USD -7.23%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.71M USD
Retained Earnings (Accumulated Deficit) -518M USD -27.1%
Stockholders' Equity Attributable to Parent 431M USD +45.2%
Liabilities and Equity 532M USD +31.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.5M USD -37.3%
Net Cash Provided by (Used in) Financing Activities 226M USD +22527%
Net Cash Provided by (Used in) Investing Activities 21.5M USD -41.8%
Common Stock, Shares Authorized 200M shares
Common Stock, Shares, Issued 49.2M shares +0.62%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 219M USD +1256%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.7M USD +45.6%
Deferred Tax Assets, Valuation Allowance 102M USD +43.2%
Deferred Tax Assets, Gross 118M USD +31%
Operating Lease, Liability 85.4M USD -4.49%
Payments to Acquire Property, Plant, and Equipment 175K USD -96.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -108M USD +10.7%
Lessee, Operating Lease, Liability, to be Paid 131M USD -8.62%
Property, Plant and Equipment, Gross 94.8M USD +8.79%
Operating Lease, Liability, Current 6.76M USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.5M USD +3.34%
Lessee, Operating Lease, Liability, to be Paid, Year One 13.4M USD +5.37%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 45.9M USD -15.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.9M USD +3.34%
Deferred Tax Assets, Operating Loss Carryforwards 43.5M USD +18.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 54.4M shares 0%
Unrecognized Tax Benefits 3.74M USD +59.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 14.4M USD +3.35%
Operating Lease, Payments 3.3M USD -43.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 9.3M USD +116%
Deferred Tax Assets, Net of Valuation Allowance 16.3M USD -14.7%
Share-based Payment Arrangement, Expense 16.3M USD -9.89%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%